Topical application of GHK-Cu accelerates wound closure (full-thickness excisional wounds in rodents, wound area tracing, digital planimetry), increases granulation tissue thickness (H&E histology), promotes re-epithelialisation (K14/K5 basal keratinocyte IHC, Ki-67 proliferation), and reduces scar width and fibrosis (Massons trichrome, collagen bundle organisation by SHG microscopy)
Rhodanese-thioredoxin system and allyl sulfur compounds: implications in apoptosis induction
Methylene blue is an FDA approved treatment for methemoglobinemia, a rare blood disorder where hemoglobin cannot effectively release oxygen to body tissues, by acting as a reducing agent to convert methemoglobin back to hemoglobin
GHK-Cu Research Areas: Skin & Hair Studies GHK-Cu research spans multiple independent laboratories worldwide, with primary focus areas including dermatological applications (wound healing acceleration, collagen synthesis stimulation, skin remodeling), hair follicle studies (follicle enlargement, growth cycle modulation), anti-inflammatory effects (reduction of TNF-alpha, IL-6 in macrophage models), and extracellular matrix remodeling (metalloproteinase regulation, glycosaminoglycan synthesis)
the copper-bound form (GHK-Cu) is the active molecule responsible for its tissue remodeling properties
